跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack
Approved
STANDARD
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
47702f980c9e7d73
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
47702f980c9e7d73
Product Name
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack
Artg Id
184837
Artg Name
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2012-05-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/900dd3b8a2eceeab9dd3606d59efa84d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f305b98a8372b93d14084665900515dc.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
47702f980c9e7d73
Type
Standard
Back to TGA Approvals